MEDICHECK
COMPANY HISTORY
Medicheck was established in Silivri to produce radiopharmaceutical products.
Strategic cooperation agreement signed with GE Healthcare.
Plant construction is completed in 8 months.
FDG technology transfer agreement was signed with GE Healthcare.
Comercial production started with SteriFDG (18F-FDG)
Distributorship agreement signed with Medi-Radiopharma.
Medicheck was qualified as service provider in radiopharmacy for GE Healthcare.
Brain-Spect (HMPAO) and Cardio-Spect (MIBI) kits were introduced to the market.
Senti-Scint (Nanocolloid) and Macro Albumon (MAA) kits were introduced to the market.
Distributorship agreement signed with GE Healthcare.
Product portfolio was expanded with SteriNaF (18F-NaF).
Flutemetamol technology transfer agreement was signed with GE Healthcare.
DaTSCAN® (123I-Ioflupane) marketing authorization was obtained.
Vizamyl® (18F-Flutemetamol) marketing authorization was obtained.
Renoscint (MAG3) Marketing Authorization application was submitted.